{"id":"W3201333387","doi":"10.1136/ijgc-2021-002973","title":"ATARI trial: ATR inhibitor in combination with olaparib in gynecological cancers with ARID1A loss or no loss (ENGOT/GYN1/NCRI)","year":2021,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Chromatin Remodeling and Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":69,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"National Institute for Health and Care Research; Cancer Research UK; European Society for Medical Oncology; Royal Marsden NHS Foundation Trust; AstraZeneca","keywords":"Olaparib; ARID1A; Medicine; Clear cell carcinoma; Cancer research; Endometrial cancer; Oncology; Serous fluid; Carcinosarcoma; Carcinoma; Internal medicine; Cancer; Mutation; Poly ADP ribose polymerase; Biology; Polymerase","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004248505,0.0002297725,0.0004163888,0.0001079986,0.00003979343,0.00006415967,0.0003884655,0.0002571484,0.000679973],"category_scores_gemma":[0.0006464735,0.0001491163,0.0001146614,0.000231486,0.0001604282,0.0000307682,0.0001094384,0.0004554428,0.000003856667],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000789359,"about_ca_system_score_gemma":0.001606908,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002157702,"about_ca_topic_score_gemma":0.008554772,"domain_scores_codex":[0.9978837,0.000161329,0.0006799749,0.0003993787,0.0005691918,0.0003064527],"domain_scores_gemma":[0.9981707,0.0001713908,0.0004073882,0.0001563329,0.0009787044,0.0001154412],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.2511336,0.006207735,0.5336977,0.0001685769,0.001827725,0.01071615,0.0006382229,0.110085,0.03529384,0.0006437725,0.009066995,0.04052065],"study_design_scores_gemma":[0.3641754,0.04153394,0.4028406,0.00211663,0.0003373079,0.002798445,0.001426902,0.004691771,0.06043186,0.001330127,0.1151418,0.00317526],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9957469,0.000427373,0.0003794179,0.001668646,0.001082218,0.0002275787,0.0000294596,0.000007388677,0.0004310192],"genre_scores_gemma":[0.9957673,0.001044243,0.0009631841,0.001009332,0.0006469075,0.00006796742,0.00004383895,0.00001977818,0.0004374309],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1308571,"threshold_uncertainty_score":0.7445228,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01654885365543387,"score_gpt":0.2995015857474742,"score_spread":0.2829527320920404,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}